A Systematic Review of Satisfaction With Teledermatology
A Systematic Review of Satisfaction With Teledermatology
Abstract
Background: The two most commonly used modalities of teledermatology (TD) are store-and-forward (SF) and live–
interactive (LI) TD. Existing studies have not compared these tools with respect to patient and provider satisfaction.
Objective: To systematically review all published studies of patient and provider satisfaction with SF and LI TD.
Methods: PubMed, EMBASE, and Cochrane databases were systematically searched for studies on provider or patient satis-
faction with SF or LI TD between January 2000 and June 2016.
Results: Forty eligible studies were identified: 32 with SF TD, 10 with LI TD, and 2 evaluating both. With SF TD, 96% of studies
assessing patient satisfaction and 82% of studies assessing provider satisfaction demonstrated satisfaction (n ¼ 24 and 17,
respectively). With LI TD, 89% of studies assessing patient satisfaction and all studies assessing provider satisfaction revealed
satisfaction (n ¼ 9 and 6, respectively).
Conclusion: Patients and providers are satisfied with both SF and LI TD. Studies assessing satisfaction with LI have not been
conducted in recent years, and have only been conducted in limited geographic patient populations. Further research assessing
satisfaction with TD will help address any dissatisfaction with its uses and allow for increased support and funding of future
programmes.
Keywords
eHealth, remote consultation, teleconsulting, teledermatology, telemedicine
Introduction Methods
Teledermatology (TD) consists of the delivery of dermato- Peer-reviewed journals listed on the PubMed (MEDLINE),
logic care from a distance using technology such as digital EMBASE, and Cochrane Library databases were searched
photography or video. The service allows physicians to for articles studying patient or physician satisfaction with
evaluate patients without an in-person appointment, and
its use has been increasing in recent years.1,2 Two widely
1
used models of the service include store-and-forward (SF) Department of Dermatology, University of Colorado Anschutz Medical
Campus, Aurora, CO, USA
and real-time or live–interactive (LI) TD.1,3 SF involves 2
Michigan State University College of Human Medicine, Grand Rapids, MI,
asynchronous sharing of patient photographs, whereas LI USA
uses synchronous videoconferencing. Advantages of SF 3
University of North Dakota School of Medicine, Grand Forks, ND, USA
4
include flexibility for consulting dermatologists and low Duke University School of Medicine, Durham, NC, USA
5
cost.4 Without instantaneous feedback, however, it can Dermatology Service, Eastern Colorado Health Care System, US
Department of Veteran Affairs, Denver, CO, USA
lead to delays in care.2 In contrast, LI provides instantan- 6
Department of Community and Behavioral Health, Colorado School of
eous feedback, but it lacks flexibility and may have greater Public Health, Aurora, CO, USA
technological requirements.2 The general trend has been an 7
Department of Dermatology, University of Pennsylvania Perelman School of
increase in use of SF systems and decrease in LI systems.5 Medicine, Philadelphia, PA, USA
Regardless of the model of delivery for TD, satisfaction
with the method of care is paramount to successful imple- Corresponding author:
Cory A Dunnick, Dermatology Service, Eastern Colorado Health Care
mentation. The primary aim of this study was to system- System, US Department of Veteran Affairs, 1665 Aurora Ct, Denver, CO
atically review published assessments of patient and 80045, USA.
provider satisfaction with SF and LI models. Email: [email protected]
2 Journal of Telemedicine and Telecare 0(0)
TD between January 2000 and June 2016. The following standardized criteria was developed to categorize studies
search terms were applied: (‘teledermatology’ AND into one of the two categories. We employed a cut-off
‘patient satisfaction’) OR (‘teledermatology’ AND ‘phys- score of at least 80% to demonstrate participant satisfac-
ician satisfaction’) OR (‘teledermatology’ AND ‘provider tion, as defined in Table 5 in the Appendix. The overall
satisfaction’) OR (‘teledermatology’ AND ‘user satisfac- quality of evidence for each article was determined using
tion’) OR (‘teledermatology’ AND ‘patient acceptance’) an abridged version of the rating scheme provided by the
OR (‘teledermatology’ AND ‘physician acceptance’) OR Oxford Center for Evidence-Based Medicine.6
(‘teledermatology’ AND ‘provider acceptance’) OR (‘tele-
dermatology’ AND ‘user acceptance’).
Results
Two reviewers independently screened all articles by title
and abstract. Exclusion criteria included articles not pub- A total of 197 articles were identified with PubMed
lished in English. Inclusion criteria were articles with quan- (n ¼ 75), EMBASE (n ¼ 112), and Cochrane Library
titative data evaluating patient or provider satisfaction or (n ¼ 10). After removing 77 duplicates, 120 articles were
acceptance with TD. Providers were further categorized screened for relevance, and 49 articles were excluded.
into referring providers (primary care physicians (PCPs), A search of 71 potentially relevant full-length articles
nurse practitioners, physician’s assistants, or nurses) vs. was conducted. Thirty-one additional articles were then
consulting dermatologists. Data collected from each study excluded: 9 articles were not available in full-text or in
included: country of origin, patient demographics, provider English, 11 did not quantify satisfaction, and 11 were
type, study method, type of TD (SF vs. LI), number of redundant with previous research. Forty publications
respondents, and measure of satisfaction. met all inclusion criteria (Figure 1).
Studies were categorized into those that demonstrated Of the 40 studies investigated, 33 studies assessed
satisfaction and those that did not. Because the studies either patient or provider satisfaction with SF TD. Eleven
varied in how satisfaction was reported, a set of of these studies (28%) originated in the United States.
Study
Quality demonstrates N
Country Authors Year of evidencea Outcome measure(s) satisfaction Respondents
Other studies originated from Austria, England, the providers.36,42 Five studies assessed both patient and pro-
Netherlands, and Australia (n ¼ 5, n ¼ 4, n ¼ 3, and n ¼ 2, vider satisfaction with LI TD. The largest number of stu-
respectively). Studies revealed dissatisfaction with SF TD in dies was conducted in the United States (n ¼ 3), and one
1 of 24 studies assessing patients and 3 of 17 studies assess- study was conducted in each of these other countries:
ing providers (Tables 1 and 2).7–39 Eight of these studies India, England, New Zealand, Norway, South Africa,
assessed both patient and provider satisfaction with SF. Jordan, and Spain. Of the nine studies assessing patient
Nine studies on patient satisfaction and six studies on satisfaction with LI TD, one demonstrated dissatisfaction
provider satisfaction with LI TD were reviewed (Tables 3 (11%). No studies assessing provider satisfaction demon-
and 4).36,40–47 Two of these studies queried non-physician strated dissatisfaction.
4 Journal of Telemedicine and Telecare 0(0)
Study
Quality N respondents demonstrates
Country Author Year of evidence Outcome measure(s) (type of provider) satisfaction
Study
Quality demonstrates N
Country Authors Year of evidence Outcome measure(s) satisfaction respondents
Study
Quality N respondents demonstrates
Country Author Year of evidence Outcome measure(s) used (type of provider) satisfaction
India Rajagopal et al.36 B 2009 PCS, 2 Overall satisfaction n/a referring Yes
England Gilmour et al.40 P 1998 NRCT, 2 TD’s educational benefit, value, 27 referring PCPs Yes
and ability to allow for a
satisfactory response
New Zealand Oakley et al.42 P
2004 CSS, 4 Ability of TD to provide educa- 4 referring PCPs and nurse Yes
tional and professional benefits
Norway Nordal et al.43 P
2001 CCS, 3 Feeling of contact with patient, 2 consulting dermatologists Yes
impression of the patient’s
confidence in provider, under-
standing of the patient’s
problem
South Africa Mars and Dlova45 P
2008 CSS, 4 Overall satisfaction 1 referring physician, 2 consult- Yes
ing dermatologists (assessed
together)
USA Lowitt et al.47 P
1998 CCS, 3 Satisfaction with ability to 4 consulting resident and Yes
examine skin attending dermatologists
Confidence with the diagnosis Yes
Abbreviations: FTF ¼ face-to-face, PCP ¼ primary care physician, TD ¼ teledermatology.
Notes: PStudy also reported patient satisfaction.
B
Study assessed both live–interactive and store-and-forward TD.
lack of explanation regarding their diagnosis or treatment the inability for the service to meet the demands of the
plan.12 The authors mentioned that complaints regarding patients.12 In contrast, Bowns et al.’s 2006 UK study
the provider-patient relationship often stemmed from eld- revealed that while patients were generally satisfied with
erly patients. Referring physicians, nurse practitioners, SF TD, both referring physicians and consulting derma-
and physician assistants reported positive experiences tologists had several concerns.24 These included the time
with the service, with their concerns mainly focusing on consuming nature of the service, increased workload
6 Journal of Telemedicine and Telecare 0(0)
involved, and technological complications experienced.24 patient or provider satisfaction. To standardize responses
A recent study further identified higher levels of satisfac- reporting satisfaction, we generated a point scale to apply
tion with TD among referring PCPs than consulting to all studies (see Appendix, Table 5). Second, the major-
dermatologists. Dermatologists reported concern with ity of studies assessing patient or provider satisfaction
liability, financial reimbursement, and diagnostic reliabil- with LI TD were over 10 years old, and therefore may
ity of the tool.8 no longer represent the current view of TD among
In terms of LI TD, only 38% of 122 patients in Gilmour patients and providers, especially in an age of rapid
et al.’s 1998 study preferred teleconsultation as compared technological advancement. Finally, because we did not
to a normal consultation.40 While this finding was not fully perform a meta-analysis of the studies, the potential for
explained, the technology was recently introduced at the publication bias exists.
time that the study was conducted, and numerous patients
expressed discomfort and embarrassment with the video-
conferencing.40 Our systematic review reveals that the
Conclusions
majority of studies evaluating patient or provider satisfac- This systematic review demonstrates that high levels of
tion with LI TD were performed more than 10 years ago, satisfaction with both store-and-forward and live–inter-
with the greatest number of studies peaking between 1997 active TD exist among patients, referring providers, and
and 2001. Consistent with this, a recent study suggested teledermatologists alike. Studies assessing satisfaction
that the use of LI TD has decreased in recent years, with the service have mainly occurred in developed coun-
likely because SF TD provides increased time efficiency tries. More recent studies of satisfaction among users
for the provider.49 An updated assessment of LI TD worldwide are required as this method of care expands
would be informative, especially given new developments in use and technology continues to evolve.
in technology. For example, a recent Japanese study
assessed asymmetric digital subscriber line (DSL)-based Declaration of Conflicting Interests
TD, which employs copper telephone lines instead of the The authors declared no potential conflicts of interest with
conventional voice band modem. The newly developed respect to the research, authorship, and/or publication of this
device was easy to manoeuvre and achieved high-resolution article.
images at an increased speed. The authors note that the
device is particularly cost efficient in rural hospitals that Funding
have limited access to live dermatologists.50 The authors received no financial support for the research,
Our study further identifies a need for additional authorship, and/or publication of this article.
research on satisfaction with TD in developing countries.
The majority of studies assessing patient or provider sat- References
isfaction with TD were conducted in developed countries. 1. Wurm EM, Hofmann-Wellenhof R, Wurm R, et al.
While both developed and developing countries may bene- Telemedicine and teledermatology: past, present and future.
fit from TD, further assessment of area-specific patient JDDG 2008; 6: 106–112.
preferences in developing countries must be conducted 2. Armstrong AW, Kwong MW, Ledo L, et al. Practice models
to allow for optimal care. Teledermatology possesses and challenges in teledermatology: a study of collective experi-
important implications in developing countries, as the ences from teledermatologists. PLoS One 2011; 6: e28687.
number of patients may grossly outnumber physicians. 3. Pathipati AS, Lee L and Armstrong AW. Health-care deliv-
A combination of poor infrastructure and significant dis- ery methods in teledermatology: consultative, triage and
ease burden negatively impacts access to health care in direct-care models. J Telemed Telecare 2011; 17: 214–216.
4. Loane MA, Gore HE, Bloomer SE, et al. Preliminary results
these areas.51–53 While poor internet connectivity and lim-
from the Northern Ireland arms of the UK Multicentre
ited computer access have made the implementation of Teledermatology Trial: is clinical management by real-time
both SF and LI TD challenging, new technological teledermatology possible? J Telemed Telecare 1998;
advances in camera resolution, mobile telephones with 4(Suppl 1): 3–5.
cameras (Tables 1 and 2), and wireless connectivity have 5. Peart JM and Kovarik C. Direct-to-patient teledermatology
made both SF and LI TD a reality in the developing practices. J Am Acad Dermatol 2015; 72: 907–909.
world.50,54 Several recent studies explore the feasibility 6. Phillips B, Ball C, Sackett D, et al. Oxford Centre for
of SF TD in remote areas of Egypt and Ghana, where Evidence-based Medicine: levels of evidence. Oxford: Oxford
limited access to computers with Internet capabilities Centre for Evidence-based Medicine, 2009.
exists.54,55 Another study investigated the use of SF TD 7. Horsham C, Loescher LJ, Whiteman DC, et al. Consumer
in 12 sub-Saharan African countries with a physician to acceptance of patient-performed mobile teledermoscopy for
the early detection of melanoma. Br J Dermatol 2016; 175:
patient ratio of roughly 10 per 100,000. The study sup-
1301–10.
ported the ability of SF TD to increase access to care in 8. Ogbechie OA, Nambudiri VE and Vleugels RA.
remote and underserved areas.56 Teledermatology perception differences between urban pri-
This study has several limitations. First, we observed mary care physicians and dermatologists. JAMA Dermatol
marked variability in the way different studies reported 2015; 151: 339–140.
Mounessa 7
9. Whited JD, Warshaw EM, Edison KE, et al. Effect of 27. Koller S, Hofmann-Wellenhof R, Hayn D, et al.
store and forward teledermatology on quality of life: Teledermatological monitoring of psoriasis patients on bio-
a randomized controlled trial. JAMA Dermatol 2013; 149: logic therapy. Acta Dermato-venereol 2011; 91: 680–685.
584–591. 28. Klaz I, Wohl Y, Nathansohn N, et al. Teledermatology:
10. Thind CK, Brooker I and Ormerod AD. Teledermatology: a quality assessment by user satisfaction and clinical effi-
tool for remote supervision of a general practitioner with ciency. Israel Med Assoc J 2005; 7: 487–490.
special interest in dermatology. Clin Exp Dermatol 2011; 29. Eminovic N, De Keizer NF, Wyatt JC, et al.
36: 489–494. Teledermatologic consultation and reduction in referrals to
11. Kvedar JC, Menn ER, Baradagunta S, et al. dermatologists: a cluster randomized controlled trial. Arch
Teledermatology in a capitated delivery system using distrib- Dermatol 2009; 145: 558–564.
uted information architecture: design and development. 30. Eminovic N, Witkamp L, de Keizer NF, et al. Patient per-
Telemed J 1999; 5: 357–366. ceptions about a novel form of patient-assisted telederma-
12. Weinstock MA, Nguyen FQ and Risica PM. Patient and tology. Arch Dermatol 2006; 142: 648–649.
referring provider satisfaction with teledermatology. J Am 31. Kaliyadan F, Amin TT, Kuruvilla J, et al. Mobile teleder-
Acad Dermatol 2002; 47: 68–72. matology: patient satisfaction, diagnostic and manage-
13. McKoy KC, DiGregorio S and Stira L. Asynchronous tele- ment concordance, and factors affecting patient refusal to
dermatology in an urban primary care practice. Telemed J participate in Saudi Arabia. J Telemed Telecare 2013; 19:
eHealth 2004; 10(Suppl 2): S70–S80. 315–319.
14. Lopez AM, Avery D, Krupinski E, et al. Increasing access to 32. Ou MH, West GA, Lazarescu M, et al. Evaluation of
care via tele-health: the Arizona experience. J Ambulatory TELEDERM for dermatological services in rural and
Care Manage 2005; 28: 16–23. remote areas. Artif Intell Med 2008; 44: 27–40.
15. Binder B, Hofmann-Wellenhof R, Salmhofer W, et al. 33. Whited JD, Hall RP, Foy ME, et al. Patient and clinician
Teledermatological monitoring of leg ulcers in cooperation satisfaction with a store-and-forward teledermatology con-
with home care nurses. Arch Dermatol 2007; 143: 1511–1514. sult system. Telemed J eHealth 2004; 10: 422–431.
16. Hsueh MT, Eastman K, McFarland LV, et al. 34. McFarland LV, Raugi GJ and Reiber GE. Primary care
Teledermatology patient satisfaction in the Pacific provider and imaging technician satisfaction with a teleder-
Northwest. Telemed J eHealth 2012; 18: 377–381. matology project in rural Veterans Health Administration
17. Livingstone J and Solomon J. An assessment of the cost- clinics. Telemed J eHealth 2013; 19: 815–825.
effectiveness, safety of referral and patient satisfaction of a 35. Barbieri JS, Nelson CA, Bream KD, et al. Primary care
general practice teledermatology service. London J Primary providers’ perceptions of mobile store-and-forward teleder-
Care 2015; 7: 31–35. matology. Dermatol Online J 2015; 21: 1–5.
18. Ford JA and Pereira A. Does teledermatology reduces sec- 36. Rajagopal R, Sood A and Arora S. Teledermatology in Air
ondary care referrals and is it acceptable to patients and Force: our experience. Med J Armed Forces India 2009; 65:
doctors?: a service evaluation. J Eval Clin Pract 2015; 21: 342–346.
710–716. 37. Van der Heijden JP, de Keizer NF, Voorbraak FP, et al.
19. Fruhauf J, Krock S, Quehenberger F, et al. Mobile teleder- A pilot study on tertiary teledermatology: feasibility and
matology helping patients control high-need acne: a rando- acceptance of telecommunication among dermatologists.
mized controlled trial. J Eur Acad Dermatol Venereol 2015; J Telemed Telecare 2010; 16: 447–453.
29: 919–924. 38. Janardhanan L, Leow YH, Chio MT, et al. Experience with
20. Fruhauf J, Schwantzer G, Ambros-Rudolph CM, et al. Pilot the implementation of a web-based teledermatology system
study on the acceptance of mobile teledermatology for the in a nursing home in Singapore. J Telemed Telecare 2008;
home monitoring of high-need patients with psoriasis. 14: 404–409.
Australas J Dermatol 2012; 53: 41–46. 39. Orruño E, Gagnon MP, Asua J, et al. Evaluation of tele-
21. Azfar RS, Weinberg JL, Cavric G, et al. HIV-positive dermatology adoption by health-care professionals using a
patients in Botswana state that mobile teledermatology modified technology acceptance model. J Telemed Telecare
is an acceptable method for receiving dermatology care. 2011; 17: 303–307.
J Telemed Telecare 2011; 17: 338–340. 40. Gilmour E, Campbell SM, Loane MA, et al. Comparison of
22. Ruiz C, Gaviria C, Gaitán M, et al. Concordance studies of teleconsultations and face-to-face consultations: preliminary
a web based system in teledermatology. Colombia Med 2009; results of a United Kingdom multicentre teledermatology
40: 259–270. study. Br J Dermatol 1998; 139: 81–87.
23. Williams T, May C, Esmail A, et al. Patient satisfaction with 41. Hicks LL, Boles KE, Hudson S, et al. Patient satisfaction
store-and-forward teledermatology. J Telemed Telecare with teledermatology services. J Telemed Telecare 2003; 9:
2001; 7(Suppl 1): 45–46. 42–45.
24. Bowns IR, Collins K, Walters SJ, et al. Telemedicine in 42. Oakley AM and Rennie MH. Retrospective review of tele-
dermatology: a randomised controlled trial. Health dermatology in the Waikato, 1997–2002. Australas J
Technol Assess 2006; 10: 1–39. Dermatol 2004; 45: 23–28.
25. Hofmann-Wellenhof R, Salmhofer W, et al. Feasibility and 43. Nordal EJ, Moseng D, Kvammen B, et al. A comparative
acceptance of telemedicine for wound care in patients with study of teleconsultations versus face-to-face consultations.
chronic leg ulcers. J Telemed Telecare 2006; 12(Suppl 1): 15–17. J Telemed Telecare 2001; 7: 257–265.
26. Ebner C, Wurm EM, Binder B, et al. Mobile teledermatol- 44. Al Quran HA, Khader YS, Ellauzi ZM, et al. Effect of real-
ogy: a feasibility study of 58 subjects using mobile phones. time teledermatology on diagnosis, treatment and clinical
J Telemed Telecare 2008; 14: 2–7. improvement. J Telemed Telecare 2015; 21: 93–99.
8 Journal of Telemedicine and Telecare 0(0)